WHO scales back suspected Ebola cases to 116 as testing clarifies diagnoses

321 confirmed Ebola cases with 49 deaths across DRC and Uganda; 6 recoveries recorded; outbreak occurred in conflict-affected region with limited medical resources.
Testing had finally caught up to suspicion.
The WHO's dramatic revision of suspected cases reflected improved surveillance methodology rather than outbreak improvement.

In the Democratic Republic of Congo, a number that once loomed at over 900 has been reduced to 116 — not because the danger receded, but because knowledge advanced. The World Health Organisation's revision of suspected Ebola cases reflects the slow, painstaking work of testing cutting through the fog of fever in a region where malaria, meningitis, and conflict all conspire to obscure the truth. With 321 confirmed cases and 49 deaths across the DRC and Uganda, and no approved vaccine or treatment for the Bundibugyo strain, what has been gained is not safety — but clarity, which is where every real response must begin.

  • An 87% drop in suspected cases sounds like relief, but it is really the sound of a diagnostic system finally catching up to an outbreak that had been spreading silently for weeks before anyone declared it.
  • The Bundibugyo strain's flu-like onset allowed it to move undetected through conflict-fractured Ituri province, blending into the background noise of malaria, typhoid, and meningitis that already fills the region's overstretched clinics.
  • Hundreds of suspected deaths were quietly removed from the count — people who died weeks or months ago, whose bodies could not be exhumed, whose causes will remain permanently unknown.
  • With no vaccine and no approved treatment, the entire containment strategy rests on the most fragile of foundations: finding cases fast enough, in a region where infrastructure and stability are both in short supply.
  • The revised numbers do not signal the outbreak is shrinking — they signal that the real work of tracing, isolating, and breaking transmission chains is only now beginning in earnest.

The number had been cut by nearly nine-tenths — not because the outbreak had eased, but because testing had finally caught up to suspicion. The World Health Organisation announced that suspected Ebola cases in the Democratic Republic of Congo had fallen from over 900 to 116 in a single week. As of May 31, 321 cases were confirmed across the region, with 48 deaths in the DRC and one in Uganda, where nine confirmed cases had been registered. Six people had recovered.

The revision reflected a shift in understanding rather than a shift in the outbreak itself. Patients arriving at health facilities with fever and body aches were logged as suspected cases — standard protocol. But many, once tested, turned out to have malaria, meningitis, or typhoid. The Bundibugyo strain circulating in conflict-affected Ituri province, where the outbreak was declared on May 15, mimics those diseases in its early days. That mimicry had generated a fog of uncertainty that testing was now burning away. The WHO had also quietly retired a category of 223 suspected deaths — people who had died weeks or months earlier, whose causes could not be verified.

The outbreak had likely been spreading for weeks before it was named, moving through a region already fractured by conflict and poverty, in a country of over 100 million people with healthcare infrastructure strained by years of instability. Early symptoms — fever, malaise — could be almost anything, allowing transmission to continue unrecognized.

What the revised numbers offered was not reassurance but precision. No vaccine exists for this strain. No approved treatment either. Containment depends entirely on finding cases, isolating them, and tracing contacts — work that can only begin with certainty. The drop from 900 to 116 meant surveillance was learning to distinguish signal from noise. It also meant that in Ituri, the real work of stopping an outbreak had only just begun.

The number that mattered most had just been cut by nearly nine-tenths. On Tuesday, the World Health Organisation announced that suspected Ebola cases in the Democratic Republic of Congo had plummeted from over 900 to 116 in the span of a week. The revision was not because the outbreak had suddenly vanished. It was because testing had finally caught up to suspicion.

As of May 31, the WHO confirmed 321 cases of Ebola across the region, with 48 deaths in the DRC and one in neighbouring Uganda, where nine confirmed cases had been registered. Six people had recovered. The numbers were grim, but they were also real—tested, verified, known. Everything else had been cleared away.

The dramatic scaling back reflected a shift in how the outbreak was being understood. When a person showed up at a health facility with fever, body aches, or other early symptoms that could suggest Ebola, they were counted as suspected. That was the protocol. But many of those people, once tested, turned out to have malaria. Others had meningitis. Some had typhoid. The Bundibugyo strain of Ebola, the one circulating in the conflict-affected Ituri province where the outbreak was declared on May 15, mimics these diseases in its opening days. That mimicry had created a fog of uncertainty that testing was now burning away.

Christian Lindmeier, the WHO spokesman, explained the mechanics to reporters with the patience of someone used to translating epidemiology for the anxious. When suspected cases were tested and ruled out, they simply dropped from the count. When they were confirmed, they moved to the confirmed list. The fluctuation was not chaos. It was clarity arriving in stages. The previous figures had included 223 suspected deaths, a category the WHO had now abandoned. Those numbers had been too uncertain—they included people who had died weeks or months earlier, whose bodies could not be exhumed for testing, whose causes remained unknowable.

The outbreak itself had likely been spreading for weeks before May 15, moving quietly through a region already fractured by conflict. The initial symptoms—fever, malaise, the kind of sickness that could be almost anything—meant that infected people might move through communities, seek treatment, recover or die, without anyone recognizing what was happening. A central African country of more than 100 million people, already among the world's poorest, with healthcare infrastructure strained by years of instability, was not an ideal place for early detection.

What made the moment significant was not that the numbers had shrunk, but that they had become trustworthy. The WHO had no vaccine for this strain. No approved treatment existed. Containment depended entirely on the basics: finding cases, isolating them, tracing contacts, breaking chains of transmission through close contact and bodily fluids. That work could only begin with certainty. The revision from 900 suspected cases to 116 meant that surveillance was working—that the system was learning to distinguish signal from noise, that resources could be focused where they were actually needed. It also meant that somewhere in the DRC, in a region already struggling with conflict and poverty, the real work of stopping an outbreak was only now beginning in earnest.

Once suspected cases were tested, many were ruled out—cases of malaria, meningitis, and others—and dropped from the suspected list.
— WHO spokesman Christian Lindmeier
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why did the number drop so dramatically? Did people stop getting sick?

Model

No. Testing revealed that most of those 900 suspected cases were actually other diseases—malaria, meningitis, typhoid. The Bundibugyo strain looks like the flu at first, so anyone with a fever got counted as suspected until they could be tested.

Inventor

So the outbreak is smaller than we thought?

Model

We don't know yet. The 321 confirmed cases are real. But the virus was likely spreading undetected for weeks before May 15, when it was officially declared. In a conflict zone with limited healthcare, early detection is nearly impossible.

Inventor

What happens now without a vaccine or treatment?

Model

Everything depends on finding cases quickly and isolating them before they spread to others. That's harder in a region already fractured by conflict and poverty.

Inventor

How many people have actually recovered?

Model

Six so far. The case fatality rate among confirmed cases is high—roughly 15 percent—but that number will shift as more people either recover or die.

Inventor

Is the WHO confident in these numbers now?

Model

More confident than before, yes. But the revision also shows how much uncertainty still exists. They dropped an entire category of suspected deaths because the bodies couldn't be tested. In a place like this, the true toll is always harder to know than the official count.

Quer a matéria completa? Leia o original em EWN ↗
Fale Conosco FAQ